Article R1221-41
At the request of the Agence nationale de sécurité du médicament et des produits de santé, the establishments mentioned in the first paragraph of Article R. 1221-40 shall collect and keep all the info…
20+ full codes, 2,400+ articles translated and updated. Case law linked to every article. Read the actual text before you ask a lawyer about it — free, no login required.
20+
french codes
Fully translated
2,400+
articles in English
Updated regularly
480+
court rulings linked
Per article
Free
full access
No login required
Showing 5681–5690 of 13025 articles for “Art. Euronext Harmonised Market Rules — derivatives”
At the request of the Agence nationale de sécurité du médicament et des produits de santé, the establishments mentioned in the first paragraph of Article R. 1221-40 shall collect and keep all the info…
In the establishments referred to in Article R. 5121-187, the person administering the blood-derived medicinal product to the patient completes the dispensing and administration slip with the followin…
…ss otherwise agreed, claims that the partners have against each other are assessed according to the rules set out in Article 1469. These claims may be set off against the advantages that their holder…
…led)3° Failure by a pharmaceutical company exploiting a medicinal product or product subject to the marketing authorisation provided for in article L. 5121-8 to communicate the date of marketing of th…
…istributors and ask them to bring the products they offer to the public into compliance with safety rules and then to submit them for inspection, within a specified period and at their own expense, by…
…in Article 18 of Regulation (EU) No 1093/2010, or an adverse development that is likely to threaten market liquidity or the stability of the financial system of another Member State of the European Un…
…tioned in Article 1 of Regulation (EU) 2017/745 is prohibited or regulated; 4° The arrangements for market surveillance of the same devices by the Agence nationale de sécurité du médicament et des pro…
…rs that a reagent presents risks to public health, including as a result of non-compliance with the rules laid down in this chapter, the Director General of the Agence nationale de sécurité du médicam…
…ntended species ; 3° The qualitative and quantitative composition of the active ingredients; 4° The rules governing the prescription and supply of the medicinal product; 5° The therapeutic indications…
The Extraordinary General Meeting of a company whose shares are admitted to trading on a regulated market and whose existing investment certificates represent no more than 1% of the share capital may…
Avocate au Barreau de Paris
Toque #C2396
15+ Years In French Corporate Practice
English · French · Russian
Ready When You Are
A 20–30 minute call, in English, to scope the engagement. No obligation, no preliminary fee. You will leave the call with a clear view of what the work will cover and what it will cost.
20+ full codes and 2,400+ articles in English, with the key court rulings linked to every article — free to read.
Read MoreA lawyer-reviewed report explaining how the relevant articles apply to your situation, with case-law analysis and next steps.
Read MoreScope your matter with a Paris-Bar avocate — incorporation, contracts, disputes — handled bilingually, end to end.
Read More